Clinical considerations for the treatment of patients with familial chylomicronemia syndrome using a hepatic-targeted APOC3 antisense oligonucleotide

Familial chylomicronemia syndrome (FCS) is a rare, typically debilitating genetic disorder of extreme hypertriglyceridemia associated with high triglyceride levels and elevated risk for recurrent acute pancreatitis. Diagnosis of FCS is frequently delayed due to its rarity, and treatment options are...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Archna Bajaj, Elif A. Oral, Alan Brown, Daniel Gaudet, Veronica J. Alexander, Ewa Karwatowska-Prokopczuk, Seth J. Baum
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2025-12-01
Rangatū:	American Journal of Preventive Cardiology
Ngā marau:	Familial chylomicronemia syndrome Hypertriglyceridemia Olezarsen Antisense oligonucleotide Apolipoprotein C-III Acute pancreatitis
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S2666667725004271
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!